Loading...

The current price of BTTC is 2.69 USD — it has decreased -2.18 % in the last trading day.
Black Titan Corporation is a holding company that operates through its subsidiaries, Titan Pharmaceuticals Inc. (TTNP), and TalenTec Sdn Bhd (TalenTec). TTNP is a pharmaceutical company that was previously developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix that is designed to be administered sub-dermally in a brief, outpatient procedure and is removed in a similar manner at the end of the treatment period. TalenTec is a provider of HCM software in Malaysia. It has introduced numerous human capital management (HCM) solutions to that market, such as Oracle PeopleSoft HCM, Oracle PeopleSoft Financials, Sunfish Workplaze HR, DayForce HCM, and MiHCM Cloud, through its holistic, integrated and reliable services.
Wall Street analysts forecast BTTC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BTTC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Black Titan Corp revenue for the last quarter amounts to 36.90 USD, increased 27.68 % YoY.
Black Titan Corp. EPS for the last quarter amounts to USD, decreased % YoY.
Black Titan Corp (BTTC) has 0 emplpoyees as of December 15 2025.
Today BTTC has the market capitalization of 19.83M USD.